biosimilars
-
Biologics
3 Big Healthcare Trends Wall Street Is Overlooking
By Cheryl Swanson The chief market strategists at Wall Street’s biggest banks and investment firms don’t get things right all…
Read More » -
Biologics
Congress should hold oversight hearings to ensure FDA prioritizes safety for biosimilars
By James Weisman The Food and Drug Administration recently approved the first in a new category of biologic drugs known…
Read More » -
Hospitals
Congress Should Hold Oversight Hearings to Ensure FDA Prioritizes Safety for Biosimilars | Commentary
By James Weisman The Food and Drug Administration recently approved the first in a new category of biologic drugs known…
Read More » -
Hospitals
UNITED SPINAL URGES CONGRESS TO HOLD OVERSIGHT HEARINGS ON BIOSIMILAR MEDICINES TO ENSURE FDA PRIORITIZES SAFETY
WASHINGTON, April 16, 2015 /PRNewswire-USNewswire/ — United Spinal Association, a national organization dedicated to enhancing the quality of life of all people living…
Read More »